Technical Articles

In the battlefield of cancer treatment, immunotherapy is gradually becoming a key force to change the rules of the game. In recent years, scientists have discovered a new class of immune checkpoint proteins - B7-H3 and B7-H4, which are abnormally expressed in many cancers and have become new targets for immunotherapy.